Dr. Robert Jarvik, who was a key designer of the first permanent artificial heart implanted in a human, died on Monday in his ...

AbCellera today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL575, an investigational antibody antagonist targeting ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

WEKA, the AI-native data platform company, announced that it has been recognized as a Customers' Choice in the 2025 Gartner®?Peer Insightstm?Voice of the Customer: File and Object Storage Platforms ...

The Jarvik-7 artificial heart, made of aluminum and plastic, was implanted in 1982 in a retired Des Moines, Wash., dentist, Barney Clark. He lived for 112 days.

He worked with a team at the University of Utah to create a mechanical heart. It was later used in patients awaiting an organ ...

Boston Scientific has pulled global sales of, and is no longer seeking FDA approval for, its Acurate neo2 and Acurate Prime aortic valve systems. In a May 28 Securities and Exchange Commission filing, ...

Artificial organ development is propelled by new developments in material science, biotechnology, and regenerative medicine. Scientists are trying out many methods, among them 3D printing, to produce ...

On March 6, he underwent a successful donor heart transplant after relying on the BiVACOR Total Artificial Heart for 105 days. The patient, who wishes to remain anonymous, had severe end-stage ...

With fewer moving parts than other artificial hearts that typically involve flexing chambers or pumping diaphragms, BiVacor’s titanium heart is expected to last 10 years or more, much longer ...